Formulation and Evaluation of Microballoons of Ramipril
DOI:
https://doi.org/10.37591/rrjodfdp.v5i2.115Keywords:
Microballoons, Ramipril, Eudragit E100, HPMC K4M, Emulsion solvent evaporation method, Stability study.Abstract
The present study was an attempt to develop microballoons of Ramipril to prolong gastric residence time in stomach and to control drug release in therapeutic range. Ramipril is ACE inhibitor having short half-life of 2–4 h and bioavailability 28%. Microballoon was formulated using Eudragit E100 and HPMC K4M in different ratios by emulsion solvent evaporation technique using methanol as evaporating solvent and liquid paraffin as a processing medium. Microballoons were characterized for micromeritic properties, drug entrapment efficiency, in vitro buoyancy, drug polymer compatibility study, scanning electron microscopy and in vitro release studies. Microballoons were white, free flowing and spherical in shape. It showed 53.23–86.03% of entrapment and release extended up to 12 h. Two months of stability study was carried out at 30±2°C (65±5%RH) for best F8 formulation which showed no significant changes in % drug entrapment efficiency and in vitro release study.
Keywords: Microballoons, Ramipril, Eudragit E100, HPMC K4M, emulsion solvent evaporation method, stability study
Cite this Article
Gandhi Sonam M, Bhumika Patel, Roopa Karki, et al. Formulation and Evaluation of Microballoons of Ramipril. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2018; 5(2): 13–30p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |